Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Merck & Company Inc (MRK)

NYSE
Symbol
Exchange
Currency
MRKNYSEUSD
0QAHLondonUSD
MRKMexicoMXN
1MRKXMilanEUR
MRKXetraEUR
MRKTradeGateEUR
MRKFrankfurtEUR
MRKBuenos AiresARS
MRCK34B3BRL
MRKViennaEUR
MRKUkraineUAH
MRKLimaUSD
Currency in USD
Disclaimer
127.01
+0.13(+0.10%)
Closed
After Hours
126.94-0.07(-0.06%)

MRK Comments

Pump and dump
Merck pill can not finish Covid pandemic. We will see new variants in near future. Very difficult to modify it against new variants. After pandemic finished, it can be considered as a treatment option to limited number of patients.
just wrong......the whole point of the pill is that it is likely to be effective to a very broad range of possible variants: " Since molnupiravir does not target the spike protein of the virus - the target of all current COVID-19 vaccines - which defines the differences between the variants, the drug should be equally effective as the virus continues to evolve, said Jay Grobler, head of infectious disease and vaccines at Merck."
mrk go go to the moon
mrmrmrmrm okay short again pff
BIONTECH go go go
and so on shorts closed of today now friday shorts in play
even almost 85$ this woumd bring me in loss but confident in a fall tho.
This stock is misleading by media. There are many global pharmaceutical companies at this stage. PUMP AND DUMP. DON'T JOIN IN.
merck just joined to late, pfizer jnj, astrazeneca, moderna all earned billions by selling vaccine now 0 intrest still when the first mentioned announced it u saw instant govs buying it now 0 headlines of interested gov. its a storm in a glass but good to short tho. those from today can be closed on friday shorts merxk evaluated on earnings as big as moderna lol wanna see that play out.
aha looks pre market like i have a new around 84$ possibility still under 80$ target. no one gonna take a pill against a flu thats mental. good that merck has its pill now but when almost everyone is vaccinated by the moderna pfizer astranzeneca merck has lowkey expectations if it was a year ago yes then it was a buy now to late lol only fools buy merck on vaccine optimism pros selling remember defensive never sustain thr fly they alwzys come back in a timeframe of 3-4 days as news was friday today is second day by ekd week merck back 77$ where the trend is for next 7years?
There will be more strains of this virus because sadly “mostly everyone” being vaccinated wont happen because there are too many people who are too stubbon and ignorant about vaccines. But im sure thise same people will willimg take a pill. And….There will be more pandemics in the future.
i dont think even with 100+ new waves that people gonna choose pills over a injection
‼️‼️October 3, Financial Times: Covid is NOT OVER, NEW VACCINES ARE ON THE WAY. CEO of BioNTech, Dr. Ugur Sahin, “This virus will STAY, and the virus will further ADAPT,” he said. “We have NO REASON to assume that the next generation virus will be easier to handle for the immune system than the existing generation. This is a CONTINIOUS EVOLUTION, and that evolution has JUST STARTED.”By next year, there will be two main streams to vaccination programmes, Sahin predicted. There will be booster shots for those who have already been vaccinated, as well as a continued push to vaccinate people that have had minimal access so far.
I am happy my stock is going up. So we will get to take a new unproven drug and still are denied proven Ivermectin and Hydroquinalone. Big pharma at it's best. FDA decides on profit.
Merck pill: It is hard to argue that a ribonucleoside precursor to both RNA and DNA goes into one but not the other. Also, the known mutagenicity of hydroxylamine (which generates dNHC in DNA) suggests that if DNA repair could target such a small change in a base, it must do so in an incomplete way. This leads to the conclusion that treatment with molnupiravir will lead to mutations in host DNA in dividing cells. Using negative results to justify this risk as being unimportant is to create a blind spot for potential long-term harm. Until a better understanding of treatment with molnupiravir is achieved, we would argue that its use should be limited to people with co-factor risks for coronavirus disease 2019 who are likely to receive the greatest benefit while being exposed to the unknown long-term risks of exposure to this mutagen.Source: Oxford Academic, The Journal of Infectious Disease jiab363
Agreed. Government at what it does best. Population control -
This pills Change the game , pills against virus was never exist. MRK was the best investing even without this game change.
what ia best selling price
If.....again..IF FDA aproves...this will easily double or triple within few months....
tq bro
ooo really excited rocket mrk
Oh..man so excited to buy....this will 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀😎🚀😎😎😎😎
This is huge! But make sure to hedge with MRNA and BNTX, as Therapeutics and vaccines work hand in hand...or arm in arm...
pizza hut delivers alot better and healthier then pills ;)
You have FOMO, don’t worry, there are always new opportunities
im shorting lol
how much of u guys did trade merck earlier? then u shoumd know merck never sustains big upmove as its defensive stock if u guys buy this on hope this is moderna 2.0 u soon get wiped
Thats ok with me. Run up to 400 then take drop over a few days.
nice dreams
they never created a pill like this before.
83.85 & 84.23 for tp under 80 ATLEAST like posted in dax forum on the opening
in the POST COVID WORLD, Merck has now become an essential hold in every portfolio, more will add it as time goes on
forget about the 50% reduction in hospitalizations .... THERE WERE 0, yes 0 DEATHS
Now everyone is going to stop being vaccinated because of a drug with 50% efficacy that still has no forecast to reach the market and we don't even know the price?
700 per course without insurance i think ..also 50% reduction is hospitalization by 0 deathers... it elinimated mortaility in the trials!
Even if you are thinking of vaccine efficacy, this trumps it. Many vaccines are well under 50% with for the new variants.
Even if you are thinking of vaccine efficacy, this trumps it. Many vaccines are well under 50% with for the new variants.
2 big shorts placed i target atleast under 80$ merck cant never hold this, people odnt even want a *****in their bloodvessel how u think people gonna accept a oral pill that literally damages whole body at risk lol mentally, just like remsidivir by gilead pump on optimism & sell on every spike on end = good profits
I don't understand the logic of the shortsellers they short stocks that have superbullish news like MRK and leave stocks like bntx, mrna where dropped hugely alone. Stupidity at its best.
If the drug gets approved, it's going to fly.
it gonna be approved but worthless no one wants a pill lol winter is coming the normal flu season ****also coming lol
...
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.